Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening Ischemia

计划入组 90 人 · 首次发布于 2007 年 2 月 13 日

Impact of Nutritional and Inflammatory Status in Patients With Critical Limb-threatening Ischemia

计划入组 310 人 · 首次发布于 2021 年 2 月 16 日

The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice

计划入组 998 人 · 首次发布于 2020 年 6 月 30 日

MFH-244

Limb Girdle Muscular Dystrophy 2g(CRD)

Limb Girdle Muscular Dystrophy 2b(CRD)

CRITICAL THERAPEUTICS

United States

PIRAMAL CRITICAL CARE

United States

Critical Biologics Corporation

United States

Stempeutics Licenses Stem Cell Therapy Stempeucel to Japanese Partner for Critical Limb-Threatening Ischemia Treatment

BioGenCell's Personalized Cell Therapy BGC101 Receives FDA Fast Track Designation for Critical Limb Threatening Ischemia

Medistim Launches PATENT Study to Improve Outcomes in Critical Limb Ischemia Bypass Surgery